109 related articles for article (PubMed ID: 18689268)
1. Human melanoma cells release soluble and functional receptors.
Badr G; Sayed D
Egypt J Immunol; 2006; 13(2):23-31. PubMed ID: 18689268
[TBL] [Abstract][Full Text] [Related]
2. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.
Murata T; Obiri NI; Debinski W; Puri RK
Biochem Biophys Res Commun; 1997 Sep; 238(1):90-4. PubMed ID: 9299458
[TBL] [Abstract][Full Text] [Related]
3. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
4. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
5. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
6. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo.
Chen W; Tabata Y; Gibson AM; Daines MO; Warrier MR; Wills-Karp M; Hershey GK
J Allergy Clin Immunol; 2008 Sep; 122(3):625-32. PubMed ID: 18694590
[TBL] [Abstract][Full Text] [Related]
8. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
[TBL] [Abstract][Full Text] [Related]
9. Differential responses of human monocytes and macrophages to IL-4 and IL-13.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Donnelly RP; Finlay-Jones JJ
J Leukoc Biol; 1999 Oct; 66(4):575-8. PubMed ID: 10534111
[TBL] [Abstract][Full Text] [Related]
10. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
Andrews AL; Holloway JW; Holgate ST; Davies DE
J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
[TBL] [Abstract][Full Text] [Related]
11. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
Kawakami K; Leland P; Puri RK
Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.
Formentini A; Braun P; Fricke H; Link KH; Henne-Bruns D; Kornmann M
Int J Colorectal Dis; 2012 Oct; 27(10):1369-76. PubMed ID: 22441356
[TBL] [Abstract][Full Text] [Related]
13. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
Donaldson DD; Whitters MJ; Fitz LJ; Neben TY; Finnerty H; Henderson SL; O'Hara RM; Beier DR; Turner KJ; Wood CR; Collins M
J Immunol; 1998 Sep; 161(5):2317-24. PubMed ID: 9725226
[TBL] [Abstract][Full Text] [Related]
14. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.
Obiri NI; Debinski W; Leonard WJ; Puri RK
J Biol Chem; 1995 Apr; 270(15):8797-804. PubMed ID: 7721786
[TBL] [Abstract][Full Text] [Related]
15. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor.
Zurawski SM; Chomarat P; Djossou O; Bidaud C; McKenzie AN; Miossec P; Banchereau J; Zurawski G
J Biol Chem; 1995 Jun; 270(23):13869-78. PubMed ID: 7775445
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.
Obiri NI; Husain SR; Debinski W; Puri RK
Clin Cancer Res; 1996 Oct; 2(10):1743-9. PubMed ID: 9816125
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R
Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184
[TBL] [Abstract][Full Text] [Related]
18. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
[TBL] [Abstract][Full Text] [Related]
19. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
